| Mrs Sarah Elizabeth Reyna, APRN | |
|
1 Medical Park Dr, Suite 200, Benton, AR 72015-3353 | |
| (501) 776-6901 | |
| (501) 776-6908 |
| Full Name | Mrs Sarah Elizabeth Reyna |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 1 Medical Park Dr, Benton, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376999607 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | A004658 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sark Opl | 7810261088 | 4 |
News Archive
The University of Massachusetts Medical School (UMMS) today announced a new two-year contract to continue to provide newborn screening services to the state of Maine.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it was awarded patent 4,546,454 entitled, "Antisense Oligonucleotides that Inhibit Expression of HIF-1," by the Japanese Patent Office.
A Swedish research team partly consisting of researchers from Uppsala University followed a group of prostate cancer patients in the Nordic region for 15 years. The study found, among other things, that surgery reduces the risk that men with prostate cancer (even those with low-risk tumours) will die within 15 years. The results were published today in the New England Journal of Medicine.
Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas MD Anderson Cancer Center.
A team of scientists from the Washington University, in St. Louis, USA, has recently conducted a survey to analyze factors responsible for coronavirus disease 2019 (COVID-19) vaccination hesitancy among US citizens.
› Verified 8 days ago
| Entity Name | South Arkansas Cardiology, P.l.l.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568567188 PECOS PAC ID: 2264699479 Enrollment ID: O20120131000149 |
News Archive
The University of Massachusetts Medical School (UMMS) today announced a new two-year contract to continue to provide newborn screening services to the state of Maine.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it was awarded patent 4,546,454 entitled, "Antisense Oligonucleotides that Inhibit Expression of HIF-1," by the Japanese Patent Office.
A Swedish research team partly consisting of researchers from Uppsala University followed a group of prostate cancer patients in the Nordic region for 15 years. The study found, among other things, that surgery reduces the risk that men with prostate cancer (even those with low-risk tumours) will die within 15 years. The results were published today in the New England Journal of Medicine.
Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas MD Anderson Cancer Center.
A team of scientists from the Washington University, in St. Louis, USA, has recently conducted a survey to analyze factors responsible for coronavirus disease 2019 (COVID-19) vaccination hesitancy among US citizens.
› Verified 8 days ago
| Entity Name | Saline Clinics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447609367 PECOS PAC ID: 0547553836 Enrollment ID: O20160725001118 |
News Archive
The University of Massachusetts Medical School (UMMS) today announced a new two-year contract to continue to provide newborn screening services to the state of Maine.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it was awarded patent 4,546,454 entitled, "Antisense Oligonucleotides that Inhibit Expression of HIF-1," by the Japanese Patent Office.
A Swedish research team partly consisting of researchers from Uppsala University followed a group of prostate cancer patients in the Nordic region for 15 years. The study found, among other things, that surgery reduces the risk that men with prostate cancer (even those with low-risk tumours) will die within 15 years. The results were published today in the New England Journal of Medicine.
Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas MD Anderson Cancer Center.
A team of scientists from the Washington University, in St. Louis, USA, has recently conducted a survey to analyze factors responsible for coronavirus disease 2019 (COVID-19) vaccination hesitancy among US citizens.
› Verified 8 days ago
| Entity Name | Lonnie Harrison Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881132363 PECOS PAC ID: 7618252420 Enrollment ID: O20170317000975 |
News Archive
The University of Massachusetts Medical School (UMMS) today announced a new two-year contract to continue to provide newborn screening services to the state of Maine.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it was awarded patent 4,546,454 entitled, "Antisense Oligonucleotides that Inhibit Expression of HIF-1," by the Japanese Patent Office.
A Swedish research team partly consisting of researchers from Uppsala University followed a group of prostate cancer patients in the Nordic region for 15 years. The study found, among other things, that surgery reduces the risk that men with prostate cancer (even those with low-risk tumours) will die within 15 years. The results were published today in the New England Journal of Medicine.
Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas MD Anderson Cancer Center.
A team of scientists from the Washington University, in St. Louis, USA, has recently conducted a survey to analyze factors responsible for coronavirus disease 2019 (COVID-19) vaccination hesitancy among US citizens.
› Verified 8 days ago
| Entity Name | Sark Opl |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558893776 PECOS PAC ID: 7810261088 Enrollment ID: O20170927000871 |
News Archive
The University of Massachusetts Medical School (UMMS) today announced a new two-year contract to continue to provide newborn screening services to the state of Maine.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it was awarded patent 4,546,454 entitled, "Antisense Oligonucleotides that Inhibit Expression of HIF-1," by the Japanese Patent Office.
A Swedish research team partly consisting of researchers from Uppsala University followed a group of prostate cancer patients in the Nordic region for 15 years. The study found, among other things, that surgery reduces the risk that men with prostate cancer (even those with low-risk tumours) will die within 15 years. The results were published today in the New England Journal of Medicine.
Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas MD Anderson Cancer Center.
A team of scientists from the Washington University, in St. Louis, USA, has recently conducted a survey to analyze factors responsible for coronavirus disease 2019 (COVID-19) vaccination hesitancy among US citizens.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Sarah Elizabeth Reyna, APRN 1 Medical Park Dr, Suite 200, Benton, AR 72015-3353 Ph: (501) 776-6901 | Mrs Sarah Elizabeth Reyna, APRN 1 Medical Park Dr, Suite 200, Benton, AR 72015-3353 Ph: (501) 776-6901 |
News Archive
The University of Massachusetts Medical School (UMMS) today announced a new two-year contract to continue to provide newborn screening services to the state of Maine.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it was awarded patent 4,546,454 entitled, "Antisense Oligonucleotides that Inhibit Expression of HIF-1," by the Japanese Patent Office.
A Swedish research team partly consisting of researchers from Uppsala University followed a group of prostate cancer patients in the Nordic region for 15 years. The study found, among other things, that surgery reduces the risk that men with prostate cancer (even those with low-risk tumours) will die within 15 years. The results were published today in the New England Journal of Medicine.
Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas MD Anderson Cancer Center.
A team of scientists from the Washington University, in St. Louis, USA, has recently conducted a survey to analyze factors responsible for coronavirus disease 2019 (COVID-19) vaccination hesitancy among US citizens.
› Verified 8 days ago
Kortney Kai Spann, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4110 Darla Dr, Benton, AR 72015 Phone: 501-317-5099 | |
Rebecca Hendricks, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 824 Military Rd, Benton, AR 72015 Phone: 501-574-3019 | |
Natalie Rodriguez, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 630 West South Street, Benton, AR 72015 Phone: 501-860-7150 | |
Ms. Jennifer Faughn Neighbors, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Dr, Benton, AR 72015 Phone: 501-776-6000 | |
Mrs. Linda Joyce Kirby, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6857 Hilo Ave, Benton, AR 72019 Phone: 501-860-9846 | |
Rhonda Teneal Hill, RN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6701 Highway 67, Benton, AR 72015 Phone: 501-315-3344 | |
Ms. Kathleen Diane Whitney, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6640 Congo Rd, Benton, AR 72019 Phone: 501-794-4110 Fax: 501-316-9360 |